Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

NCT00981370 is registered in ClinicalTrials.gov with Children's Hospital Los Angeles as lead sponsor.

NCT NCT00981370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00981370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Lead sponsor
Children's Hospital Los Angeles
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2009
Completion date
December 31, 2010
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, sickle cell, transfusion hemosiderosis